Evidence map›Paper›PMID 30199560›Full record

ArticleJornal brasileiro de nefrologia

Anca-associated crescentic glomerulonephritis in a child with isolated renal involvement.

Mehtap Ezel Çelakıl, Burcu Bozkaya Yücel, Umay Kiraz Özod, Kenan Bek

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Jornal brasileiro de nefrologia. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 84% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 2 countries.

Mehtap Ezel ÇelakılKocaeli University, School of Medicine, Department of Pediatric Nephrology and Pathology, Kocaeli, Turkey.
Burcu Bozkaya YücelKocaeli University, School of Medicine, Department of Pediatric Nephrology and Pathology, Kocaeli, Turkey.
Umay Kiraz ÖzodKocaeli University, School of Medicine, Department of Pediatric Nephrology and Pathology, Kocaeli, Turkey.
Kenan BekKocaeli University, School of Medicine, Department of Pediatric Nephrology and Pathology, Kocaeli, Turkey.ORCID http://orcid.org/0000-0002-1005-2379
American Society of Nephrology · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pauci-immune glomerulonephritis (GN) is more common in elderly people compared to children and the etiology is not completely understood yet. Antineutrophil cytoplasmic antibody (ANCA) positivity occurs in 80% of the patients. We report a case of a 7-year-old girl who presented with malaise and mildly elevated creatinine diagnosed as ANCA-associated pauci-immune crescentic glomerulonephritis with crescents in 20 of 25 glomeruli (80%). Of these 20 crescents, 12 were cellular, 4 fibrocellular, and 4 globally sclerotic. She did not have purpura, arthritis, or systemic symptoms and she responded well to initial immunosuppressive treatment despite relatively severe histopathology. The patient was given three pulses of intravenous methylprednisolone (30 mg/kg on alternate days) initially and continued with cyclophosphamide (CYC; 2 mg/kg per day) orally for 3 months with prednisone (1 mg/kg per day). In one month, remission was achieved with normal serum creatinine and prednisone was gradually tapered. The case of this child with a relatively rare pediatric disease emphasizes the importance of early and aggressive immunosuppressive treatment in patients with renal-limited ANCA-associated pauci-immune crescentic GN even if with a mild clinical presentation. As in our patient, clinical and laboratory findings might not always exactly reflect the severity of renal histopathology and thus kidney biopsy is mandatory in such children to guide the clinical management and predict prognosis.

Indexed as

Antibodies, Antineutrophil CytoplasmicAnti-Inflammatory AgentsBiopsyChildCreatinineCyclophosphamideFemaleFollow-Up StudiesGlomerulonephritisHumansImmunosuppressive AgentsKidneyMethylprednisolonePrednisoneTreatment OutcomeAntibodies, Antineutrophil CytoplasmicAnti-Inflammatory AgentsCreatinineCyclophosphamideImmunosuppressive AgentsMethylprednisolonePrednisone

Identifiers

PMID30199560
PMCPMC6699429
OpenAlexW2889641310

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.